The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $142.45

Today's change-1.15 -0.80%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $142.45

Today's change-1.15 -0.80%
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Edwards Lifesciences Corp down (U.S.)$1.15

Edwards Lifesciences Corp closed lower Thursday, dropping (U.S.)$1.15 or 0.80% to (U.S.)$142.45. Shares have lost 1.49% over the last five days, but have gained 11.83% over the last year to date. This security has outperformed the S&P 500 by 57.72% during the last year.

Key company metrics

  • Open(U.S.) $144.14
  • Previous close(U.S.) $143.60
  • High(U.S.) $144.55
  • Low(U.S.) $141.12
  • Bid / Ask-- / --
  • YTD % change+11.83%
  • Volume857,280
  • Average volume (10-day)963,965
  • Average volume (1-month)1,057,342
  • Average volume (3-month)1,108,572
  • 52-week range(U.S.) $84.05 to (U.S.) $150.41
  • Beta0.74
  • Trailing P/E17.63×
  • P/E 1 year forward33.31×
  • Forward PEG2.46×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $8.08
Updated July 2 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+36.57%

Based on its net profit margin of 36.57%, Edwards Lifesciences Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.30%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue590618607575
Total other revenue--------
Total revenue590618607575
Gross profit454458439424
Total cost of revenue136160168151
Total operating expense428485487-238
Selling / general / administrative203223222216
Research & development86848889
Depreciation / amortization--------
Interest expense (income), net operating4444
Unusual expense (income)0114-697
Other operating expenses, total0010
Operating income163133121813
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax163133121813
Income after tax12310995547
Income tax, total392426266
Net income12310995547
Total adjustments to net income--------
Net income before extra. items12310995547
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items12310995547
Inc. avail. to common incl. extra. items12310995547
Diluted net income12310995547
Dilution adjustment----00
Diluted weighted average shares110110108107
Diluted EPS excluding extraordinary itemsvalue per share1.121.000.875.09
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.121.080.900.73